$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full…
November 21, 2025 16:30 ET | Source: Conavi Medical Corp. PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION…
Company Announcement COPENHAGEN, Denmark; November 20, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided…
November 18, 2025 16:51 ET | Source: Olema Oncology SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc.…
November 12, 2025 22:55 ET | Source: Annexon Biosciences BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”)…
Vancouver, British Columbia, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE:…
August 15, 2025 10:15 ET | Source: DIAGNOS Inc. BROSSARD, Quebec, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”…
MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader…
Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage…
July 25, 2025 20:00 ET | Source: Diginex Limited LONDON, July 25, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or…